We are live on
!
Find out more
HLA
Hamilton Lane Advisors Portfolio holdings
AUM
$149M
1-Year Est. Return
14.17%
This Fund
S&P 500
This Quarter
Est. Return
+13.81%
1 Year Est. Return
-14.17%
3 Year Est. Return
+186.76%
5 Year Est. Return
+98.42%
10 Year Est. Return
+778.69%
AUM
$228M
AUM Growth
-$71.5M
(-24%)
Cap. Flow
-$91.8M
Cap. Flow
% of AUM
-40.29%
Top 10 Holdings %
Top 10 Hldgs %
70.64%
Holding
67
New
7
Increased
5
Reduced
10
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ROVR
Rover Group, Inc. Class A Common Stock
ROVR
|
+$4.46M |
| 2 |
GTM
ZoomInfo Technologies
GTM
|
+$4.08M |
| 3 |
Riskified
RSKD
|
+$2.92M |
| 4 |
Snowflake
SNOW
|
+$2.09M |
| 5 |
Flywire
FLYW
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
monday.com
MNDY
|
+$91.4M |
| 2 |
Airbnb
ABNB
|
+$3.36M |
| 3 |
UiPath
PATH
|
+$2.94M |
| 4 |
Cloudflare
NET
|
+$2.15M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$1.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 36.15% |
| 2 | Technology | 33.33% |
| 3 | Energy | 11.01% |
| 4 | Consumer Discretionary | 7.82% |
| 5 | Healthcare | 4.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pinterest
PINS
$13.4B
| $1.59M | 0.7% |
58,057
| – | – |
|
27
Denali Therapeutics
DNLI
$3.75B
| $1.54M | 0.68% |
+52,129
| New | +$1.47M |
|
|
NARI
28
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $1.45M | 0.64% |
24,900
| – | – |
|
29
Datadog
DDOG
$94.6B
| $1.44M | 0.63% |
14,590
| – | – |
|
|
KRTX
30
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.1M | 0.48% |
5,061
-9,222
| -65% | -$1.98M |
|
31
Doximity
DOCS
$3.75B
| $1.08M | 0.47% |
31,790
-36,042
| -53% | -$1.2M |
|
32
10x Genomics
TXG
$6.01B
| $1.05M | 0.46% |
18,731
+10,988
| +142% | +$595K |
|
33
Elastic
ESTC
$6.71B
| $1M | 0.44% |
15,632
| – | – |
|
34
Payoneer
PAYO
$2.42B
| $803K | 0.35% |
166,924
| – | – |
|
|
DOCU
35
DocuSign
DOCU
$10.3B
| $744K | 0.33% |
14,565
| – | – |
|
36
Recursion Pharmaceuticals
RXRX
$1.59B
| $721K | 0.32% |
96,474
| – | – |
|
37
Evolv Technologies
EVLV
$991M
| $591K | 0.26% |
+98,500
| New | +$466K |
|
38
ChargePoint
CHPT
$139M
| $571K | 0.25% |
3,246
| – | – |
|
|
SMAR
39
DELISTED
Smartsheet Inc.
SMAR
| $534K | 0.23% |
13,946
| – | – |
|
40
Enovix
ENVX
$870M
| $525K | 0.23% |
+33,278
| New | +$387K |
|
|
SEMR
41
DELISTED
Semrush
SEMR
| $467K | 0.21% |
48,828
| – | – |
|
42
Guardant Health
GH
$21.6B
| $382K | 0.17% |
10,660
| – | – |
|
43
Natera
NTRA
$37.9B
| $348K | 0.15% |
7,145
| – | – |
|
44
C3.ai
AI
$1.43B
| $342K | 0.15% |
9,382
| – | – |
|
|
MORF
45
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $308K | 0.14% |
+5,364
| New | +$280K |
|
|
NEWR
46
DELISTED
New Relic, Inc.
NEWR
| $290K | 0.13% |
4,424
| – | – |
|
|
XYZ
47
Block Inc
XYZ
$48.3B
| $287K | 0.13% |
4,317
| – | – |
|
48
XPeng
XPEV
$12.3B
| $227K | 0.1% |
16,903
| – | – |
|
49
Humacyte
HUMA
$177M
| $151K | 0.07% |
52,693
| – | – |
|
50
Inhibikase Therapeutics
IKT
$341M
| $49.8K | 0.02% |
13,802
-1
| -0% | -$4 |
|
Similar funds
FFS
KCM
GCA
DAC
RCM
AWA
JWM
AWF
Hamilton Lane Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Hamilton Lane Advisors held 67 positions worth $228M, down 24% from $299M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Hamilton Lane Advisors withdrew a net $91.8M in Q2 2023, closing 14 positions and reducing 10 holdings. Its most notable exit was UiPath, an estimated $2.94M position sold in full.
By sector, the portfolio is most concentrated in Financials at 36% of assets, up from 27% a quarter earlier, followed by Technology and Energy.
Against the trend, Hamilton Lane Advisors opened a new position in Rover Group, Inc. Class A Common Stock worth $4.79M.
- Hamilton Lane Advisors's largest Q2 2023 buy was Rover Group, Inc. Class A Common Stock: 975,719 shares worth $4.79M.
- Hamilton Lane Advisors added most to ZoomInfo Technologies in Q2 2023, an estimated $4.08M increase.
- Hamilton Lane Advisors's biggest Q2 2023 reduction was monday.com, cutting an estimated $91.4M.
- Hamilton Lane Advisors fully exited UiPath in Q2 2023, selling an estimated $2.94M.
- Hamilton Lane Advisors's ten largest holdings make up 71% of its $228M portfolio in Q2 2023.
- Hamilton Lane Advisors opened 7 new positions and closed 14 in Q2 2023.
- Hamilton Lane Advisors's portfolio value fell 24% quarter-over-quarter to $228M.
Based on Hamilton Lane Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.